Clinical Trials on LCC

Total 359 results

Seton Healthcare Family
University of Texas at Austin; Dell Medical School at The University of Texas...

Withdrawn

Intraoperative Margin Assessment During Mohs Surgery

Basal Cell Carcinoma (BCC) | Squamous Cell Carcinoma (SCC)
UNC Lineberger Comprehensive Cancer Center
National Cancer Institute (NCI); Food and Drug Administration (FDA)

Not yet recruiting

Little Cigar and Cigarillo Warnings for Youth

Little Cigars and Cigarillos (LCC) Using

United States
Leiden University Medical Center
Medtronic; ZonMw: The Netherlands Organisation for Health Research and Development and other collaborators

Completed

Holmium Radioembolization as Adjuvant Treatment to RFA for Early Stage HCC: Dose Finding Study (HORA EST HCC)

HCC | Early Stage HCC

Netherlands
Qianfoshan Hospital

Not yet recruiting

Study of Serum Tumor Markers of HBV Associated HCC

HCC
University of Pisa
Azienda Ospedaliera Città della Salute e della Scienza di Torino; Fondazione... and other collaborators

Recruiting

Occlusafe® Assisted MW Alone or With DEB-TACE Compared to MW With DEB-TACE in the Treatment of HCC (SEASON-HCC)

HCC

Italy
Seoul National University Hospital
Philips Healthcare

Completed

"Double Low-Dose" DECT for HCC Imaging

HCC

Korea, Republic of
Huazhong University of Science and Technology

Unknown

PD-1 Monoclonal Antibody Plus Apatinib Combined With SBRT in HCC With PVTT

HCC

China
Taipei Medical University WanFang Hospital

Terminated

Statin With Palliative Therapy for HCC

HCC

Taiwan
Qianfoshan Hospital

Not yet recruiting

Study of Long Non-coding RNA SNHG15 as a Novel Biomarker in HBV Associated HCC

HCC
Xuhua Duan

Recruiting

DEB-TACE Versus DEB-TACE Sequential HAIC for Unresectable BCLC Stage C HCC; A Randomized Controlled Trial

HCC

China
Ain Shams University

Completed

Salvage Living Donor Liver Transplantation for HCC Beyond All Criteria Yield Equivalent Results to Milan Criteria

Hcc
Shenyang Tenth People's Hospital
Beijing Tsinghua Changgeng Hospital

Not yet recruiting

Lenalidomide to Reverse Drug Resistance After First-line Treatment of Advanced HCC

Advanced HCC
Access Vascular Inc

Completed

A Comparative, Retrospective Chart Review of Intended Dwell Time of a PICC Line

PICC | Peripheral ICC

United States
Genentech, Inc.

Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

Melanoma | Cervical Cancer | HCC | Gastric Cancer | Esophageal Cancer | NSCLC | Urothelial Carcinoma | HNSCC | Locally Advanced or Metastatic Solid Tumors | TNBC | Clear Cell RCC

Korea, Republic of, Netherlands, Spain, United States, Australia, Canada, Belgium
Ain Shams University

Completed

TAURINE and HCC PATIENTS

Taurine in HCC

Egypt
Chen Xiaoping

Recruiting

Triple vs. Dual Adjuvant Therapy Following Liver Resection for HCC.

HCC

China
Henan Cancer Hospital

Not yet recruiting

Tace With Icaritin in First-line Treatment of Middle and Advanced HCC in Child Grade B Patients

HCC
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Regina Elena Cancer Institute

Recruiting

Accurate Dosimetry and Biomarkers Improve Survival in HCC Patients Treated With Resin 90 Yttrium (90Y)-Microspheres (DOSEY90)

HCC

Italy
The First Affiliated Hospital of Zhengzhou University

Unknown

Clinical Study on the Efficacy of Acetazolamide Combined With Levamisole in the Treatment of HCC

HCC

China
feng xiaobin

Unknown

ERAS Program Improves Recovery of HCC Patient Undergoing Hepatectomy

HCC

China
Tang-Du Hospital
Xijing Hospital; Sun Yat-sen University; Shaanxi Provincial People's Hospital; Air... and other collaborators

Completed

A New Conception About Individualized Treatment Allocation for HCC (PTA4HCC)

HCC | Resection | Transarterial Chemoembolization
University of Bologna
University of Pisa; Azienda Ospedaliera Città della Salute e della Scienza... and other collaborators

Completed

Equity and Efficacy of Allocation Priority for Liver Transplantation Patients With MELD≥30 in Italy

HCC | Liver Transplant Disorder
Seoul National University Hospital
Bayer

Completed

Added Value of Gadoxetic Acid-enhanced Liver MRI

Diagnosis | Hcc

Korea, Republic of
University of Florida

Not yet recruiting

Virtual Planning of ALT Flap

Tongue SCC
Teleflex
Duke University

Enrolling by invitation

Vascular Positioning System G4 Algorithm ECG Data Collection for Model Training Study

Peripheral ICC

United States
RenJi Hospital
Peking University First Hospital; Fudan University; Shanghai Zhongshan Hospital; First Affiliated Hospital, Sun Yat-Sen University and other collaborators

Recruiting

Molecular Markers in Predicting Response to Treatment in FH-deficient RCC Patients

Biomarkers | FH-Deficient RCC | Systemic Treatments

China
SparX Biotech(Jiangsu) Co., Ltd.

Recruiting

A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors (SPX-303)

Solid Tumor | CRC | HNSCC | RCC

United States
Shanghai Kanda Biotechnology Co., Ltd.

Not yet recruiting

KD6001 in Combination With Anti-PD-1 Antibody±Bevacizumab in Patients With Advanced HCC and Other Solid Tumors

Other Solid Tumors | Advanced HCC

China
Eirion Therapeutics Inc.

Active, not recruiting

ET-01 in Subjects With Lateral Canthal Lines, LCL-210

Crow's Feet | Lateral Canthal Lines, LCL

United States
Valérie LAURENT

Completed

CT Perfusion Parameters for Advanced HCC Treated by Systemic Immunotherapy

Advanced HCC Treated by Systemic Immunotherapy

France
Eirion Therapeutics Inc.

Completed

ET-01 in Subjects With Lateral Canthal Lines, LCL-209

Crow's Feet | Lateral Canthal Lines, LCL

United States
Chinese University of Hong Kong

Not yet recruiting

SBRT in HCC With Oligoprogression on Atezo-Bev

HCC

Hong Kong
The University of Hong Kong
Merck KGaA, Darmstadt, Germany

Completed

Sequential TACE and SBRT Followed by ImmunoTherapy for Downstaging HCC for Hepatectomy (START-FIT)

HCC

Hong Kong
Seoul National University Hospital
Taejoon Pharmaceutical Co., Ltd.; Reyon Pharmaceutical Co., Ltd.

Completed

A Study of HCC High Risk Group Using Two Surveillance Tools

HCC

Korea, Republic of
The Affiliated Nanjing Drum Tower Hospital of Nanjing...

Unknown

Phase IB/II Study of NRT Combined With Radiotherapy for Advanced HCC (LCRAI-1)

HCC
The First Affiliated Hospital of Zhengzhou University
Anyang Tumor Hospital; Luoyang Central Hospital; Nanyang Central Hospital; Sanmenxia... and other collaborators

Recruiting

Novel Treatment of Advanced Hepatocellular Carcinoma (NTAHCC)

HCC

China
Istituto Clinico Humanitas

Completed

18F-FDG PET in HCC Patients Candidate to Treatment With Sorafenib

HCC

Italy
Assiut University

Unknown

Risk of HCC in Cirrhotic Patients Post DAAs Ttt

HCC
Galderma R&D

Completed

Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination (READY-3)

Glabellar Frown Lines (GL) | Lateral Canthal Lines (LCL)

United States, Canada
Beijing 302 Hospital

Unknown

OBT Measurement to Differentiate Between Presence and Absence of HCC Determined by MRI

HCC
Tel-Aviv Sourasky Medical Center
Merck Sharp & Dohme LLC

Unknown

the Effect of Grazoprevir/Elbasvir and TACE vs. TACE Alone in Prolonging Survival of Patients With Non-resectable HCV Associated HCC. (ZEPATIER)

HCV, HCC
Boston Scientific Corporation

Completed

Subcutaneous Implantable Defibrillator (S-ICD) System - CE Clinical Investigation

ACC/AHA/NASPE Class 1, IIa or IIb Indications

Netherlands, Italy, United Kingdom, New Zealand
Assiut University

Not yet recruiting

Association Between Serum Ferritin Level and Severity of Liver Disease and Development of HCC in Cirrhotic Patients

HCC
Pulse Biosciences, Inc.

Completed

CellFX Treat & Resect Low-Risk BCC Feasibility Study

BCC | BCC - Basal Cell Carcinoma | Excision Margin

United States
Stephen Chan Lam

Recruiting

CXD101 in Immunotherapy-related Liver Cancer

HCC

Hong Kong
Geneos Therapeutics

Active, not recruiting

GNOS-PV02 Personalized Neoantigen Vaccine, INO-9012 and Pembrolizumab in Subjects With Advanced HCC

HCC

United States, New Zealand
Tongji Hospital

Completed

A Novel MSE Score to Predict rHCC Patients

HCC
Chen Xiaoping

Not yet recruiting

Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model

HCC
Hannover Medical School

Completed

Elimination of CD4+CD25+ Regulatory T Cells in Patients With Hepatocellular Carcinoma

Advanced HCC

Germany
Chen Xiaoping

Not yet recruiting

Efficacy and Safety of Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model.

HCC

Clinical Trials on LCC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations